Babar, Zaheer-Ud-Din <br/><br/>
The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.  [electronic resource] 

 -  PharmacoEconomics  Nov 2013 
 - 1063-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-2027 
<br/><br/><label>Standard No.: </label>10.1007/s40273-013-0095-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Albuterol--economics<br/>Anti-Asthmatic Agents--economics<br/>Asthma--drug therapy<br/>Beclomethasone--economics<br/>Budesonide--economics<br/>Cross-Sectional Studies<br/>Data Collection<br/>Developing Countries<br/>Drug Costs<br/>Glucocorticoids--economics<br/>Health Services Accessibility--statistics & numerical data<br/>Humans<br/>Reimbursement Mechanisms